Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod

Mult Scler. 2016 Jun;22(7):969-71. doi: 10.1177/1352458516629560. Epub 2016 Feb 9.

Abstract

Fingolimod-related viral infections have been described on several occasions since its introduction in 2010. We hereby add a report on an otherwise immunocompetent, 18-year old Caucasian man with relapsing-remitting multiple sclerosis who developed a protracted and extensive molluscum contagiosum (MC) virus infection shortly after being started on fingolimod. Wide-spread cutaneous MC infections in adult patients are considered indicative of underlying immunosuppression. Neurologists prescribing fingolimod ought to be aware of a possibly increased risk of MC, but also need to know about its relative benignity, lack of extra-cutaneous complications, and adequate treatment options.

Keywords: Fingolimod; immunosuppression; molluscum contagiosum; poxvirus.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Biopsy
  • Fingolimod Hydrochloride / adverse effects*
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Molluscum Contagiosum / chemically induced*
  • Molluscum Contagiosum / diagnosis
  • Molluscum Contagiosum / immunology
  • Molluscum Contagiosum / virology
  • Molluscum contagiosum virus / immunology*
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / immunology
  • Opportunistic Infections / chemically induced*
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / immunology
  • Opportunistic Infections / virology
  • Risk Factors

Substances

  • Immunosuppressive Agents
  • Fingolimod Hydrochloride